On August 8, TransDigm fell 3.01% in regular trading, trading at $1224.12 per share with turnover of $3.2 billion. The stock has continued to weaken since reporting strong fiscal Q3 results on August 4.

Despite Q3 adjusted EPS of $10.87 beating the consensus estimate of $10.30 by 5.5% and revenue of $2.741 billion topping the $2.676 billion forecast, the stock has faced sustained selling pressure. RBC Capital Markets noted investors are focused on risks from right-to-repair legislation, implied flat fiscal Q4 margins, limited M&A opportunities, and challenging fiscal 2027 aftermarket comparisons. Meanwhile, Stifel downgraded the stock to Hold from Buy with a reduced price target of $1,405, and Morgan Stanley maintained its Equalweight rating with a target of $1,400. Goldman Sachs modestly raised its target to $1,972 but the stock remains well below consensus estimates. The company raised its fiscal 2026 guidance to sales of $10.47-$10.55 billion versus the $10.38 billion estimate, yet valuation concerns continue to outweigh near-term earnings momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)